Market Research Report
Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Analysis By Product (Instruments, Microscopes, Automated Cell Analyzers, Services, Software), By Application, By End-use, And Segment Forecasts, 2014 - 2025
|Published by||Grand View Research, Inc.||Product code||582005|
|Published||Content info||102 Pages
Delivery time: 2-3 business days
|Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Analysis By Product (Instruments, Microscopes, Automated Cell Analyzers, Services, Software), By Application, By End-use, And Segment Forecasts, 2014 - 2025|
|Published: October 9, 2017||Content info: 102 Pages||
The global FISH imaging systems market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing R&D investments pertaining to in vitro diagnostics are expected to drive the Fluorescence In Situ Hybridization (FISH) imaging systems market. Presence of government organizations, such as the European Diagnostic Manufacturers Association that focuses on development and growth of the in vitro diagnostics market in Europe, is also contributing to growth.
Furthermore, FISH imaging systems are gaining popularity in diagnostics for determination of suspected diseases caused by pathogens or bacteria. Increasing incidence of genetic diseases, such as lymphoma, solid tumors, leukemia, autism, and other developmental syndromes, is also expected to boost adoption. Growing penetration of fluoroscopy, microscopes, illuminators, and CCD cameras in testing for infectious diseases is expanding growth opportunities for these systems. Increasing prevalence of diseases with chromosomal aberrations, such as cancer and genetic abnormalities, as well as unmet diagnostic & clinical needs in developing countries, is anticipated to drive the market.
Moreover, increasing demand for rapid, sensitive, & accurate diagnostic techniques for validation of diseases, coupled with rising awareness, increase in healthcare expenditure, and extensive R&D for development of novel imaging systems are also expected to drive growth over the forecast period.
Further Key Findings From the Report Suggest:
Instruments held the largest market, whereas FISH imaging services are expected to grow at the fastest rate during the forecast period
At present, the market penetration of FISH imaging in cancer diagnostics is very high, hence the diagnostic laboratories segment accounted for larger revenues
Cancer diagnosis held the largest revenue share owing to increasing incidence of cancer, thus fueling adoption of FISH imaging systems
Among end-use segments, companion diagnostics is expected to witness faster growth than research and diagnostic segments
Diagnostic laboratories held the dominant position in 2016 as these systems are predominantly used in various clinical studies for visualization of precancerous lesions in cervical cancer, assessing risk of human papillomavirus, and for detection of leukemia, myelodysplastic syndrome, multiple myeloma, & chromosomal abnormalities
North America held the largest revenue share owing to extensive adoption of these solutions in research and development across this region
Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to increase in investments by manufacturers & governments, supportive government initiatives in the biotechnology sector, and presence of a large number of untapped opportunities
The industry is highly competitive with a limited number of players holding a majority of the overall revenues. Some of the most notable market participants are Thermo Fisher Scientific, Inc. and General Electric Company. They account for a considerable share of the industry